相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cannabidiol for the Reduction of Cue-Induced Craving and Anxiety in Drug-Abstinent Individuals With Heroin Use Disorder: A Double-Blind Randomized Placebo-Controlled Trial
Yasmin L. Hurd et al.
AMERICAN JOURNAL OF PSYCHIATRY (2019)
Cannabinoid therapy in epilepsy
Santoshi Billakota et al.
CURRENT OPINION IN NEUROLOGY (2019)
Potential Metabolic and Behavioural Roles of the Putative Endo-cannabinoid Receptors GPR18, GPR55 and GPR119 in Feeding
Ricardo E. Ramirez-Orozco et al.
CURRENT NEUROPHARMACOLOGY (2019)
Circulating Endocannabinoids: From Whence Do They Come and Where are They Going?
Cecilia J. Hillard
NEUROPSYCHOPHARMACOLOGY (2018)
An overview of the cannabinoid type 2 receptor system and its therapeutic potential
Bihua Bie et al.
CURRENT OPINION IN ANESTHESIOLOGY (2018)
Cannabinoid Receptors and the Endocannabinoid System: Signaling and Function in the Central Nervous System
Shenglong Zou et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
The endocannabinoid system and its therapeutic exploitation in multiple sclerosis: Clues for other neuroinflammatory diseases
Valerio Chiurchiu et al.
PROGRESS IN NEUROBIOLOGY (2018)
GPR55: a new promising target for metabolism?
Eva Tuduri et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2017)
ROS-induced cleavage of NHLRC2 by caspase-8 leads to apoptotic cell death in the HCT116 human colon cancer cell line
Kensuke Nishi et al.
CELL DEATH & DISEASE (2017)
Body Fat Distribution and the Risk of Incident Metabolic Syndrome: A Longitudinal Cohort Study
Hyuktae Kwon et al.
SCIENTIFIC REPORTS (2017)
An Update on Safety and Side Effects of Cannabidiol: A Review of Clinical Data and Relevant Animal Studies
Kerstin Iffland et al.
CANNABIS AND CANNABINOID RESEARCH (2017)
An update on PPAR activation by cannabinoids
Saoirse Elizabeth O'Sullivan
BRITISH JOURNAL OF PHARMACOLOGY (2016)
Plant-Derived and Endogenous Cannabinoids in Epilepsy
Alberto Verrotti et al.
CLINICAL DRUG INVESTIGATION (2016)
Interaction between Cannabinoid System and Toll-Like Receptors Controls Inflammation
Kathleen L. McCoy
MEDIATORS OF INFLAMMATION (2016)
High-resolution crystal structure of the human CB1 cannabinoid receptor
Zhenhua Shao et al.
NATURE (2016)
Cannabigerol is a novel, well-tolerated appetite stimulant in pre-satiated rats
Daniel I. Brierley et al.
PSYCHOPHARMACOLOGY (2016)
Preclinical and Clinical Assessment of Cannabinoids as Anti-Cancer Agents
Daniel A. Ladin et al.
FRONTIERS IN PHARMACOLOGY (2016)
Impact of Cannabis, Cannabinoids, and Endocannabinoids in the Lungs
Caroline Turcotte et al.
FRONTIERS IN PHARMACOLOGY (2016)
A review of nabilone in the treatment of chemotherapy-induced nausea and vomiting
Mark Ware
Therapeutics and Clinical Risk Management (2016)
Clinical utility of dronabinol in the treatment of weight loss associated with HIV and AIDS
Melissa E. Badowski et al.
HIV AIDS-RESEARCH AND PALLIATIVE CARE (2016)
Role of adiponectin and free fatty acids on the association between abdominal visceral fat and insulin resistance
Aida Medina-Urrutia et al.
CARDIOVASCULAR DIABETOLOGY (2015)
CB2 cannabinoid receptor agonist enantiomers HU-433 and HU-308: An inverse relationship between binding affinity and biological potency
Reem Smoum et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Metabolic syndrome: a closer look at the growing epidemic and its associated pathologies
S. O'Neill et al.
OBESITY REVIEWS (2015)
Cannabinoids as therapeutic agents in cancer: current status and future implications
Bandana Chakravarti et al.
ONCOTARGET (2014)
Cyclohexa-2,5-diene-1,4-dione-based antiproliferative agents: design, synthesis, and cytotoxic evaluation
Carmen Petronzi et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2013)
Hyperlipidemia as a Risk Factor for Cardiovascular Disease
Robert H. Nelson
PRIMARY CARE (2013)
The role of endocannabinoids system in fatty liver disease and therapeutic potentials
Khalid A. Alswat
SAUDI JOURNAL OF GASTROENTEROLOGY (2013)
The Endocannabinoid System and Plant-Derived Cannabinoids in Diabetes and Diabetic Complications
Bela Horvath et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
Inhibitory effect of cannabichromene, a major non-psychotropic cannabinoid extracted from Cannabis sativa, on inflammation-induced hypermotility in mice
Angelo A. Izzo et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Cannabinoids and Atherosclerotic Coronary Heart Disease
Sandeep Singla et al.
CLINICAL CARDIOLOGY (2012)
Neuroprotective agents: Cannabinoids
A. J. Sanchez et al.
CLINICAL IMMUNOLOGY (2012)
Rimonabant, Gastrointestinal Motility and Obesity
Yan Sun et al.
CURRENT NEUROPHARMACOLOGY (2012)
Major involvement of mTOR in the PPARγ-induced stimulation of adipose tissue lipid uptake and fat accretion
Pierre-Gilles Blanchard et al.
JOURNAL OF LIPID RESEARCH (2012)
Serum contents of endocannabinoids are correlated with blood pressure in depressed women
W. S. Vanessa Ho et al.
LIPIDS IN HEALTH AND DISEASE (2012)
Endocannabinoids via CB1 receptors act as neurogenic niche cues during cortical development
Javier Diaz-Alonso et al.
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2012)
Cannabinol and cannabidiol exert opposing effects on rat feeding patterns
Jonathan A. Farrimond et al.
PSYCHOPHARMACOLOGY (2012)
Non-psychoactive cannabinoids modulate the descending pathway of antinociception in anaesthetized rats through several mechanisms of action
Sabatino Maione et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
But my Doctor Recommended Pot: Medical Marijuana and the Patient-Physician Relationship
Abraham M. Nussbaum et al.
JOURNAL OF GENERAL INTERNAL MEDICINE (2011)
Interaction between cytokines, cannabinoids and the nervous system
Lucie Jean-Gilles et al.
IMMUNOBIOLOGY (2010)
The role of the endocannabinoid system in lipogenesis and fatty acid metabolism
Roberto Vettor et al.
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
An introduction to the endocannabinoid system: from the early to the latest concepts
Luciano De Petrocellis et al.
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
A complex interplay between Akt, TSC2 and the two mTOR complexes
Jingxiang Huang et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2009)
Role of the Endocannabinoid System in Abdominal Obesity and the Implications for Cardiovascular Risk
Robert S. Rosenson
CARDIOLOGY (2009)
CB1 and CB2 cannabinoid receptors differentially regulate the production of reactive oxygen species by macrophages
Ki Hoon Han et al.
CARDIOVASCULAR RESEARCH (2009)
Ajulemic acid, a synthetic cannabinoid, increases formation of the endogenous proresolving and anti-inflammatory eicosanoid, lipoxin A4
Robert B. Zurier et al.
FASEB JOURNAL (2009)
Cannabinoids as novel anti-inflammatory drugs
Prakash Nagarkatti et al.
FUTURE MEDICINAL CHEMISTRY (2009)
Synthetic Δ-9-Tetrahydrocannabinol (Dronabinol) Can Improve the Symptoms of Schizophrenia
Glenn Schwarcz et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2009)
The future of endocannabinoid-oriented clinical research after CB1 antagonists
Bernard Le Foll et al.
PSYCHOPHARMACOLOGY (2009)
The Nuclear Factor NF-κB Pathway in Inflammation
Toby Lawrence
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2009)
Endocannabinoid System Overactivity and the Metabolic Syndrome: Prospects for Treatment
Jennifer M. Perkins et al.
CURRENT DIABETES REPORTS (2008)
Endocannabinoids, adipose tissue and lipid metabolism
C. Pagano et al.
JOURNAL OF NEUROENDOCRINOLOGY (2008)
Cannabinoids as Therapeutic Agents for Ablating Neuroinflammatory Disease
G. Cabral et al.
Endocrine Metabolic & Immune Disorders-Drug Targets (2008)
Endocannabinoid system and its implications for obesity and cardiometabolic risk
Richard W. Nesto et al.
EUROPEAN HEART JOURNAL SUPPLEMENTS (2008)
Convenient total synthesis of taranabant (MK-0364), a novel cannabinoid-1 receptor inverse agonist as an anti-obesity agent
Min-Ah Kim et al.
TETRAHEDRON (2007)
Expression and Function of Cannabinoid Receptors CB1 and CB2 and Their Cognate Cannabinoid Ligands in Murine Embryonic Stem Cells
Shuxian Jiang et al.
PLOS ONE (2007)
Rimonabant: Just an Antiobesity drug? Current evidence on its pleiotropic effects
Maurizio Bifulco et al.
MOLECULAR PHARMACOLOGY (2007)
Cannabinoid receptors in atherosclerosis
Sabine Steffens et al.
CURRENT OPINION IN LIPIDOLOGY (2006)
Metabolic syndrome and cardiovascular risk in primary hypertension
Elena Ratto et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
The actin cytoskeleton in ageing and apoptosis
CW Gourlay et al.
FEMS YEAST RESEARCH (2005)
The endocannabinoid system: Physiology and pharmacology
FR de Fonseca et al.
ALCOHOL AND ALCOHOLISM (2005)
Endocannabinoids acting at cannabinoid-1 receptors regulate cardiovascular function in hypertension
S Bátkai et al.
CIRCULATION (2004)
分享论文
